Katina DeShong

University of Wisconsin Carbone Cancer Center

ORCID: 0009-0002-1970-4262

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery”.

Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery

Cancer Prevention Research(2024)10.1158/1940-6207.capr-24-0194

N/A

0.220DataRank · unranked

2 citations

Howard H. Bailey, Taja Ložar, Natalie Schmitz, Heather Green, Cameron O. Scarlett +15 more

A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance

The Prostate(2020)10.1002/pros.24076

N/A

0DataRank · unranked

36 citations

Mikolaj Filon, Wei Huang, Tom Havighurst, Katina DeShong, KyungMann Kim +9 more

Lessons Learned from the Impact of COVID-19 on NCI-sponsored Cancer Prevention Clinical Trials: Moving Toward Participant-centric Study Designs

Cancer Prevention Research(2022)10.1158/1940-6207.capr-21-0578

N/A

0DataRank · unranked

7 citations

Margaret G. House, Kelly Benante, Lisa Bengtson, Troy Budd, Bridget Dermody +9 more